irinotecan has been researched along with Testicular Neoplasms in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 10 (62.50) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichioka, D; Kawai, K; Kimura, T; Miyazaki, J; Nishiyama, H; Suetomi, T; Takaoka, E; Uchida, M | 1 |
| Badreldin, W; Berney, D; Chowdhury, S; Frampton, AE; Harding, V; Harland, SJ; Krell, J; Mazhar, D; Shamash, J; Stebbing, J; Wilson, P | 1 |
| Gotoh, M; Hattori, R; Komatsu, T; Matsukawa, Y; Sassa, N; Yamamoto, T; Yoshikawa, Y; Yoshino, Y | 1 |
| Kitamura, H; Masumori, N; Matsuda, Y; Sato, S; Takahashi, S; Tanaka, T; Tsukamoto, T | 1 |
| Bokemeyer, C; Hentrich, M; Kanz, L; Klaproth, H; Kollmannsberger, C; Kubin, T; Kuczyk, M; Mayer, F; Rick, O; Sayer, HG; Spott, C; Welslau, M | 1 |
| Deguchi, N; Murai, M; Nonaka, S; Ueno, M; Yamazaki, R | 1 |
| Berney, D; Oliver, RT; Powles, T; Shamash, J | 1 |
| Aravantinos, G; Economopoulos, T; Farmakis, D; Gaglia, A; Kostopoulou, V; Koumpou, M; Mylonakis, N; Nikolaou, M; Pectasides, D; Pectasides, M; Raptis, SA | 1 |
| Farmakis, D; Pectasides, D; Pectasides, M | 1 |
| Akaza, H; Ando, S; Kawai, K; Shimazui, T; Takaoka, E | 1 |
| Kawauchi, A; Miki, T; Mizutani, Y; Nakamura, T; Nomoto, T | 1 |
| Nagata, Y; Shima, M; Shoji, S; Terachi, T; Uchida, T; Usui, Y | 1 |
| Ansell, W; Berney, D; Mutsvangwa, K; Oliver, T; Powles, T; Shamash, J; Stebbing, J; Walsh, E; Wilson, P | 1 |
| Kotake, T; Miki, T | 1 |
| Kojima, Y; Kotake, T; Maeda, O; Miki, T; Nonomura, N; Okuyama, A; Saiki, S; Sawada, M | 1 |
| Kotake, T; Miki, T; Nakagawa, S; Nakao, M; Nomoto, T; Nonomura, N; Saiki, S; Takada, T | 1 |
2 review(s) available for irinotecan and Testicular Neoplasms
| Article | Year |
|---|---|
Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Ifosfamide; Irinotecan; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Vinblastine | 2005 |
[Progress in therapy for testicular tumors].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Camptothecin; Cisplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Drug Administration Schedule; Etoposide; Gemcitabine; Humans; Irinotecan; Lymph Node Excision; Male; Paclitaxel; Taxoids; Testicular Neoplasms | 2006 |
4 trial(s) available for irinotecan and Testicular Neoplasms
| Article | Year |
|---|---|
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group.
Topics: Adult; Camptothecin; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Germany; Humans; Irinotecan; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2002 |
Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: a phase II study.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Irinotecan; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Testicular Neoplasms; Treatment Failure | 2004 |
A phase II study using a topoisomerase I-based approach in patients with multiply relapsed germ-cell tumours.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Follow-Up Studies; Humans; Irinotecan; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Survival Analysis; Testicular Neoplasms; Time Factors; Topoisomerase I Inhibitors; Treatment Outcome | 2007 |
[The salvage chemotherapy for refractory testicular cancer with novel anticancer agents].
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Humans; Irinotecan; Male; Organoplatinum Compounds; Salvage Therapy; Testicular Neoplasms | 1999 |
10 other study(ies) available for irinotecan and Testicular Neoplasms
| Article | Year |
|---|---|
Salvage chemotherapy with gemcitabine plus oxaliplatin for patients with testicular germ cell cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asian People; Camptothecin; Cisplatin; Deoxycytidine; Disease-Free Survival; Gemcitabine; Humans; Irinotecan; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Salvage Therapy; Testicular Neoplasms | 2014 |
The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Disease-Free Survival; Drug Resistance, Neoplasm; Humans; Irinotecan; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Retroperitoneal Neoplasms; Retrospective Studies; Salvage Therapy; Seminoma; Testicular Neoplasms; Treatment Outcome; Young Adult | 2016 |
[Case report of malignant sertoli cell tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Combined Modality Therapy; Fatal Outcome; Humans; Irinotecan; Lymph Node Excision; Lymphatic Metastasis; Male; Orchiectomy; Organoplatinum Compounds; Salvage Therapy; Sertoli Cell Tumor; Testicular Neoplasms; Tomography, X-Ray Computed | 2008 |
[Clinical features of patients with brain metastasis from testicular germ cell tumor].
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Humans; Irinotecan; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Retrospective Studies; Testicular Neoplasms; Treatment Outcome | 2010 |
SN-38 induces cell cycle arrest and apoptosis in human testicular cancer.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Camptothecin; Cell Cycle; Cell Line; Cisplatin; DNA; Etoposide; G1 Phase; Humans; In Situ Nick-End Labeling; Irinotecan; Male; Testicular Neoplasms; Tetrazolium Salts; Thiazoles | 2002 |
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group.
Topics: Camptothecin; Cisplatin; Clinical Trials, Phase II as Topic; Drug Resistance, Neoplasm; Germany; Humans; Irinotecan; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2003 |
Neutropenic colitis during standard dose combination chemotherapy with nedaplatin and irinotecan for testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chorionic Gonadotropin; Drug Administration Schedule; Enterocolitis, Neutropenic; gamma-Globulins; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Radiography, Abdominal; Testicular Neoplasms; Tomography, X-Ray Computed | 2006 |
[A case report: simultaneous bilateral testicular tumors with different cell types--complete response after combination chemotherapy of cisplatin and irrinotecan hydrochloride--].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Endodermal Sinus Tumor; Humans; Irinotecan; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasms, Multiple Primary; Remission Induction; Salvage Therapy; Seminoma; Testicular Neoplasms | 2006 |
[Advantages in combination chemotherapy using the camptothecin analogue CPT-11 and cisplatinum analogues for human testicular cancer xenografts].
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Administration Schedule; Drug Synergism; Humans; Irinotecan; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Testicular Neoplasms; Transplantation, Heterologous | 1993 |
Antitumor effect of CPT-11, a camptothecin derivative, on human testicular tumor xenografts in nude mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Humans; Irinotecan; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Teratocarcinoma; Testicular Neoplasms; Topoisomerase I Inhibitors; Transplantation, Heterologous; Vinblastine | 1997 |